. 2018 Nov 15;104(4):1221–1231. doi: 10.1210/jc.2018-00570

Table 3.

Echocardiography Parameters in Controls and in Women With srPCOS According to the Presence of Hypertension

Characteristic	Normotensive Control (n = 89–121)	Normotensive srPCOS (n = 10–16)	P Value ^a	Hypertensive Control (n = 90–146)	Hypertensive srPCOS (n = 14–21)	P Value ^b	P Value ^c	P Value ^d
LVEF biplane, %	61.77 ± 5.42	62.20 ± 4.95	0.760	61.33 ± 6.27	59.42 ± 4.59	0.204	0.077	0.559
Global strain	−22.38 ± 2.26	−21.25 ± 2.43	0.138	−20.82 ± 2.16	−20.51 ± 1.74	0.604	0.004	<0.001
IVSd, cm	0.84 ± 0.15	0.89 ± 0.12	0.165	0.91 ± 0.16	0.92 ± 0.15	0.669	0.019	<0.001
LVIDd, cm	4.95 ± 0.45	4.82 ± 0.30	0.283	5.03 ± 0.49	5.15 ± 0.42	0.311	0.066	0.160
LAESV, mL	49.98 ± 13.26	48.67 ± 14.10	0.713	51.83 ± 16.98	57.81 ± 15.48	0.160	0.024	0.345
LVMI	139.70 ± 31.88	141.79 ± 25.47	0.801	162.79 ± 39.87	170.24 ± 32.46	0.426	<0.001	<0.001
E/e′ (septal E′)	6.94 ± 1.29	6.69 ± 1.06	0.457	8.00 ± 1.77	7.66 ± 1.63	0.404	0.024	<0.001
e′ septal mitral annulus	0.13 ± 0.02	0.13 ± 0.02	0.863	0.11 ± 0.02	0.12 ± 0.02	0.203	0.044	<0.001
e′ lateral mitral annulus	0.15 ± 0.03	0.14 ± 0.03	0.275	0.13 ± 0.03	0.14 ± 0.03	0.098	0.008	<0.001

Data are presented as mean ± SD. Differences between groups were analyzed by the Student t test, as the data were normally distributed. Number of study participants in each group is shown in parentheses. Normotensive: Normal BP (systolic BP <130 mm Hg and diastolic BP <85 mm Hg) at ages 31 and 46 years and no antihypertensive medication at age 31 or 46 years. Hypertensive: Elevated BP (systolic BP ≥130 mm Hg and/or diastolic BP ≥85 mm Hg) at age 31 or 46 years or antihypertensive medication at age 31 or 46 years. Significant P values appear in boldface type.

Abbreviations: IVSd, interventricular septal end-diastole; LAESV, left atrium end-systolic volume; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal diameter end-diastole; LVMI, left ventricle mass index.

^{^a}

Comparison between normotensive PCOS and normotensive control groups.

^{^b}

Comparison between hypertensive PCOS and hypertensive control groups.

^{^c}

Comparison between hypertensive PCOS and normotensive control groups.

^{^d}

Comparison between hypertensive and normotensive control groups.